After recent publication of the first patients with disease associated missense variants in GRIN2D, we evaluate the effect of copy number variation (CNV) overlapping this gene towards the presentation of neurodevelopmental disorders.
Introduction.
N-methyl-D-aspartate (NMDA) receptors are involved in neurodevelopmental processes such as synaptogenesis, learning and memory. Structurally, NMDA receptors are composed by two subunits of GluN1 and GluN2 which are specifically encoded by the GRIN1 and GRIN2A to GRIN2D genes, respectively 1 . While single nucleotide and Copy Number Variants (CNV) in the NMDA receptor subunits GRIN1, GRIN2A and GRIN2B have been associated with a range of neurodevelopmental disorders (NDDs), little is known about the association of GRIN2D variants and NDDs. Recently, de novo missense mutations in GRIN2D (p.Val667Ile) were identified as the cause of severe epileptic encephalopathy 2 in two independent patients.
However, whether CNVs covering the GRIN2D locus are also associated with disease has not been studied. GRIN2D is encoded at the end of the long arm of chromosome 19 (19q13.33) locus. We hypothesize that dosage changes in GRIN2D are highly likely to be disease associated based on the high sequence homology, expression during neurodevelopment and a functional relationship with the established disease associated paralogs genes.
Methods.
Using the gene oriented query "GRIN2D", we accessed two publically available repositories of clinical genetic variation: 1) The Database of Chromosomal Imbalance and Phenotype in Humans using Ensembl Resources, DECIPHER 3 (URL: https://decipher.sanger.ac.uk, accessed on July 2016), and 2) The public archive of interpretations of clinically relevant variants, ClinVar 4 (URL: http://www.ncbi.nlm.nih.gov/clinvar, accessed on July 2016). For each of the identified patients, we contacted the individual scientist who deposited the entry to aquire further phenotype information including the presence of: Intellectual disability (ID), developmental delay (DD), seizures, hypotonia, dysmorphism (Dysm), learning difficulties, behavioral problems as well as social communication and behavioral disorders of the autism spectrum (ASD) 5 . All phenotypes evaluated were considered as a binary denominators (i.e. YES/NO). Gene annotations of the extracted CNVs refer to the genome build GRCh37/hg19.
Consensus region was determined with an in-house python script (available upon request).
Genes inside the consensus region were further evaluated as disease candidate genes with additional publicly available resources for: 1) Brain expression, strongly brain-expressed based on high throughput genetic and epigenetic data in order to predict tissue specific functional non-coding elements 10 .
Results.
We detected 13 patients with CNVs overlapping the 19q13.33 locus (Table 1) Table 1 . Notably, all patients were reported to have mild to severe forms of NDDs. Of all the phenotypes evaluated, mild but distinct dysmorphic features was the most frequent (n = 10), followed by seizures (n = 6, including generalized tonic and febrile seizures), developmental delay (n = 6) and intellectual disability (n = 5). In particular, dysmorphisms were present in patients carrying a CNV larger than 3mb (pathogenic size according to the American College of Human Genetics). The image of one of such patients is depicted in figure 1A , showing a child with signs of macrostomia, mid-face hypoplasia, and progenia.
For DECIPHER entries with available parental information, 80% (n= 8) of observed microduplications were de novo and only one was inherited from an affected family member.
The majority of (70%, 7/10) patients did not carry additional CNVs and none of the additional CNVs found in three patients covered a known disease locus or known disease genes. (Table 1) .
Overall, the consensus duplicated region was determined to be located within the the coordinates 48,520,809 bp -48,926,006 bp, with a final size of 405kb. This is consistent previous reports [11] [12] [13] . The consensus region overlapped 13 RefSeq genes ( Figure 1B) that were further examined for brain expression, the presence of CNVs overlapping these genes in control cohorts and variation intolerance ( Table 2) . Four genes persisted above all available filters, namely: the caspase recruitment domain family member 8 (CARD8); the chromosome 19 open reading frame 68 (C19orf68); the KDEL endoplasmic reticulum protein retention receptor 1 (KDELR1), and the glutamate ionotropic receptor NMDA type subunit 2D (GRIN2D).
In our view these four genes represent the most promising candidates.
We also searched for non-coding brain-specific functional elements within the consensus region. A total of 291 were found overlapping 9.87% of the consensus region (40,019 bp).
Within the consensus regions of the duplications, the density of non-coding elements was not significantly higher than outside of chromosome 19. Pérez-Palma, 10
Discussion.
Here we report on 13 patients with duplications at a potential novel disease locus within The NDDs observed in the 13 patients were characterized by dysmorphism as the most prominent feature, followed by intellectual disability and seizures (Table 1 ). Our observations are in agreement with previous reports [11] [12] [13] . Although, Wang et al, 2015 12 focused exclusively on seizures and we cannot rule out that other NDDs were actually present in those patients.
Similarly, we acknowledge that developmental delay, behavioral problems and learning difficulties may be subject to inter-observer variability to some extent. In this regard, future clinical studies of 19q13.33 duplication carriers need to be conducted to draw detailed and robust genotype-phenotype conclusions. Since previous reports from the literature were based on low resolution cytogenetic methods 13 , identification of the underlying disease gene was not possible. Here we show that by integration of multiple CNV datasets from public repositories we are able to narrow down the disease associated genomic sequence to a few candidate genes at 19q13.33 locus (Figure 1 ).
Our included datasets do not allow estimation of 19q13.33 duplication frequency. However, absence of 19q13.33 duplications in CNV databases of the general population and the presence of only a few variant carrying patients in diagnostic CNV databases with heterogeneous breakpoints indicate that 19q13.33 duplications are extremely rare ( Table 2 ).
All 13 of the identified patient CNVs shared a genomic interval of 405 kb, which includes four genes with genetic, population and biological support of disease association. These included
